These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
234 related articles for article (PubMed ID: 33514561)
1. SRGAP1 Controls Small Rho GTPases To Regulate Podocyte Foot Process Maintenance. Rogg M; Maier JI; Dotzauer R; Artelt N; Kretz O; Helmstädter M; Abed A; Sammarco A; Sigle A; Sellung D; Dinse P; Reiche K; Yasuda-Yamahara M; Biniossek ML; Walz G; Werner M; Endlich N; Schilling O; Huber TB; Schell C J Am Soc Nephrol; 2021 Mar; 32(3):563-579. PubMed ID: 33514561 [TBL] [Abstract][Full Text] [Related]
2. ARHGEF7 ( Matsuda J; Maier M; Aoudjit L; Baldwin C; Takano T J Am Soc Nephrol; 2020 May; 31(5):996-1008. PubMed ID: 32188698 [TBL] [Abstract][Full Text] [Related]
3. The FERM protein EPB41L5 regulates actomyosin contractility and focal adhesion formation to maintain the kidney filtration barrier. Schell C; Rogg M; Suhm M; Helmstädter M; Sellung D; Yasuda-Yamahara M; Kretz O; Küttner V; Suleiman H; Kollipara L; Zahedi RP; Sickmann A; Eimer S; Shaw AS; Kramer-Zucker A; Hirano-Kobayashi M; Abe T; Aizawa S; Grahammer F; Hartleben B; Dengjel J; Huber TB Proc Natl Acad Sci U S A; 2017 Jun; 114(23):E4621-E4630. PubMed ID: 28536193 [TBL] [Abstract][Full Text] [Related]
4. Crk1/2-dependent signaling is necessary for podocyte foot process spreading in mouse models of glomerular disease. George B; Verma R; Soofi AA; Garg P; Zhang J; Park TJ; Giardino L; Ryzhova L; Johnstone DB; Wong H; Nihalani D; Salant DJ; Hanks SK; Curran T; Rastaldi MP; Holzman LB J Clin Invest; 2012 Feb; 122(2):674-92. PubMed ID: 22251701 [TBL] [Abstract][Full Text] [Related]
5. Melanocortin therapy ameliorates podocytopathy and proteinuria in experimental focal segmental glomerulosclerosis involving a podocyte specific non-MC1R-mediated melanocortinergic signaling. Qiao Y; Wang P; Chang M; Chen B; Ge Y; Malhotra DK; Dworkin LD; Gong R Clin Sci (Lond); 2020 Apr; 134(7):695-710. PubMed ID: 32167144 [TBL] [Abstract][Full Text] [Related]
6. α-Parvin Defines a Specific Integrin Adhesome to Maintain the Glomerular Filtration Barrier. Rogg M; Maier JI; Van Wymersch C; Helmstädter M; Sammarco A; Lindenmeyer M; Zareba P; Montanez E; Walz G; Werner M; Endlich N; Benzing T; Huber TB; Schell C J Am Soc Nephrol; 2022 Apr; 33(4):786-808. PubMed ID: 35260418 [TBL] [Abstract][Full Text] [Related]
7. Mice with mutant Inf2 show impaired podocyte and slit diaphragm integrity in response to protamine-induced kidney injury. Subramanian B; Sun H; Yan P; Charoonratana VT; Higgs HN; Wang F; Lai KV; Valenzuela DM; Brown EJ; Schlöndorff JS; Pollak MR Kidney Int; 2016 Aug; 90(2):363-372. PubMed ID: 27350175 [TBL] [Abstract][Full Text] [Related]
8. The Hippo pathway regulator KIBRA promotes podocyte injury by inhibiting YAP signaling and disrupting actin cytoskeletal dynamics. Meliambro K; Wong JS; Ray J; Calizo RC; Towne S; Cole B; El Salem F; Gordon RE; Kaufman L; He JC; Azeloglu EU; Campbell KN J Biol Chem; 2017 Dec; 292(51):21137-21148. PubMed ID: 28982981 [TBL] [Abstract][Full Text] [Related]
9. Activation of RhoA in podocytes induces focal segmental glomerulosclerosis. Zhu L; Jiang R; Aoudjit L; Jones N; Takano T J Am Soc Nephrol; 2011 Sep; 22(9):1621-30. PubMed ID: 21804090 [TBL] [Abstract][Full Text] [Related]